BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,624 | -27.2% | 55,077 | -12.1% | 0.00% | -25.0% |
| Q2 2023 | $2,855,898 | +11.1% | 62,684 | -1.1% | 0.00% | 0.0% |
| Q1 2023 | $2,571,021 | -17.7% | 63,388 | +3.4% | 0.00% | -33.3% |
| Q4 2022 | $3,124,716 | -9.2% | 61,305 | -4.1% | 0.01% | -14.3% |
| Q3 2022 | $3,443,000 | -17.1% | 63,937 | -1.2% | 0.01% | -12.5% |
| Q2 2022 | $4,155,000 | -15.5% | 64,699 | +2.0% | 0.01% | +14.3% |
| Q1 2022 | $4,918,000 | -11.9% | 63,418 | -2.5% | 0.01% | 0.0% |
| Q4 2021 | $5,584,000 | +10.5% | 65,056 | +3.6% | 0.01% | 0.0% |
| Q3 2021 | $5,052,000 | -3.5% | 62,817 | -3.4% | 0.01% | -12.5% |
| Q2 2021 | $5,237,000 | -15.0% | 65,050 | -10.9% | 0.01% | -27.3% |
| Q1 2021 | $6,159,000 | +5.7% | 73,030 | +0.5% | 0.01% | +10.0% |
| Q4 2020 | $5,828,000 | -4.8% | 72,633 | -4.6% | 0.01% | -23.1% |
| Q3 2020 | $6,124,000 | -10.9% | 76,156 | -4.6% | 0.01% | -18.8% |
| Q2 2020 | $6,874,000 | +6.7% | 79,834 | +0.6% | 0.02% | -20.0% |
| Q1 2020 | $6,444,000 | -3.5% | 79,370 | -0.7% | 0.02% | +17.6% |
| Q4 2019 | $6,681,000 | -3.5% | 79,901 | +1.0% | 0.02% | -10.5% |
| Q3 2019 | $6,920,000 | +7.6% | 79,125 | +0.7% | 0.02% | +5.6% |
| Q2 2019 | $6,434,000 | -8.6% | 78,556 | -9.2% | 0.02% | -10.0% |
| Q1 2019 | $7,036,000 | +26.5% | 86,543 | +2.5% | 0.02% | +5.3% |
| Q4 2018 | $5,560,000 | -25.0% | 84,450 | -12.2% | 0.02% | -9.5% |
| Q3 2018 | $7,413,000 | +11.8% | 96,165 | +7.1% | 0.02% | +5.0% |
| Q2 2018 | $6,630,000 | -10.0% | 89,790 | -20.7% | 0.02% | -16.7% |
| Q1 2018 | $7,363,000 | +14.0% | 113,205 | +13.3% | 0.02% | +20.0% |
| Q4 2017 | $6,457,000 | +2.5% | 99,878 | -0.5% | 0.02% | -4.8% |
| Q3 2017 | $6,301,000 | -0.1% | 100,421 | -3.6% | 0.02% | +10.5% |
| Q2 2017 | $6,310,000 | +23.1% | 104,222 | +5.5% | 0.02% | +11.8% |
| Q1 2017 | $5,124,000 | +13.4% | 98,782 | -3.1% | 0.02% | +6.2% |
| Q4 2016 | $4,517,000 | -47.8% | 101,890 | -43.9% | 0.02% | -46.7% |
| Q3 2016 | $8,652,000 | +6.7% | 181,763 | +1.3% | 0.03% | +7.1% |
| Q2 2016 | $8,112,000 | +15.5% | 179,382 | +4.9% | 0.03% | +16.7% |
| Q1 2016 | $7,024,000 | +28.8% | 170,985 | +19.6% | 0.02% | +26.3% |
| Q4 2015 | $5,454,000 | +15.5% | 142,993 | -0.5% | 0.02% | +11.8% |
| Q3 2015 | $4,723,000 | -81.4% | 143,750 | -60.4% | 0.02% | -79.5% |
| Q2 2015 | $25,394,000 | -37.0% | 363,138 | -38.3% | 0.08% | -35.2% |
| Q1 2015 | $40,323,000 | -14.1% | 588,654 | -8.1% | 0.13% | -13.5% |
| Q4 2014 | $46,940,000 | +4.6% | 640,463 | +2.4% | 0.15% | +2.8% |
| Q3 2014 | $44,874,000 | +1.3% | 625,258 | +2.1% | 0.14% | +3.6% |
| Q2 2014 | $44,285,000 | +27.9% | 612,514 | +30.2% | 0.14% | +26.4% |
| Q1 2014 | $34,613,000 | +1484.1% | 470,401 | +1397.9% | 0.11% | +1471.4% |
| Q4 2013 | $2,185,000 | +8.8% | 31,404 | +2.7% | 0.01% | 0.0% |
| Q3 2013 | $2,009,000 | +40.3% | 30,589 | +48.0% | 0.01% | +16.7% |
| Q2 2013 | $1,432,000 | – | 20,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |